For research use only. Not for therapeutic Use.
Mevalonic acid (MVA) lithium salt is a precursor substance of the mevalonate pathway, which is essential for cell growth and proliferation. Mevalonic acid lithium salt is effective in inhibiting Simvastatin (HY-17502)-induced decrease in C2C12 cell viability in vitro. Mevalonic acid lithium salt can be used in studies of myopathy and heart failure[1][2].
Mevalonic acid lithium salt (80, 90, 100, 110 µM; 72 h) shows prevention of simvastatin-induced loss of viability of C2C12myotube cells in vitro[1].
Catalog Number | I046048 |
CAS Number | 2618458-93-6 |
Synonyms | lithium;3,5-dihydroxy-3-methylpentanoate |
Molecular Formula | C6H11LiO4 |
Purity | ≥95% |
InChI | InChI=1S/C6H12O4.Li/c1-6(10,2-3-7)4-5(8)9;/h7,10H,2-4H2,1H3,(H,8,9);/q;+1/p-1 |
InChIKey | PVWNXFFXFNEHDZ-UHFFFAOYSA-M |
SMILES | [Li+].CC(CCO)(CC(=O)[O-])O |
Reference | [1]. Moschetti A, et al. Coenzyme Q nanodisks counteract the effect of statins on C2C12 myotubes. Nanomedicine. 2021 Oct;37:102439. [2]. Soma MR, et al. Cholesterol and mevalonic acid modulation in cell metabolism and multiplication. Toxicol Lett. 1992 Dec;64-65 Spec No:1-15. |